These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8572628

  • 21. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M.
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [Abstract] [Full Text] [Related]

  • 22. Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients.
    Schuurman JJ, Bong SB, Einarsson R.
    Anticancer Res; 1996 Aug; 16(4B):2169-72. PubMed ID: 8694538
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J, Lorente JA, Encabo G.
    Cancer; 1996 Dec 01; 78(11):2374-8. PubMed ID: 8941009
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C, Stieber P, Untch M, Nagel D, Eiermann W, Fateh-Moghadam A.
    Anticancer Res; 1998 Dec 01; 18(2B):1243-9. PubMed ID: 9615795
    [Abstract] [Full Text] [Related]

  • 28. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
    Berruti A, Torta M, Piovesan A, Raucci CA, Orlandi F, Panero A, Dogliotti L, Angeli A.
    Anticancer Res; 1995 Dec 01; 15(6B):2871-5. PubMed ID: 8669881
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.
    Gion M, Peloso L, Mione R, Vignati G, Fortunato A, Saracchini S, Biasioli R, Gulisano M, Cappelli G.
    Cancer J; 2001 Dec 01; 7(3):181-90. PubMed ID: 11419026
    [Abstract] [Full Text] [Related]

  • 32. A prospective evaluation of CA15-3 in stage I carcinoma of the breast.
    O'Hanlon DM, Kerin MJ, Kent PJ, Skehill R, Maher D, Grimes H, Given HF.
    J Am Coll Surg; 1995 Feb 01; 180(2):210-2. PubMed ID: 7850057
    [Abstract] [Full Text] [Related]

  • 33. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
    Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC.
    Clin Chem; 1998 Oct 01; 44(10):2139-47. PubMed ID: 9761247
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Skeletal alkaline phosphatase as a serum marker of bone metastases in the follow-up of patients with breast cancer.
    Reale MG, Santini D, Marchei GG, Manna A, Del Nero A, Bianco V, Marchei P, Frati L.
    Int J Biol Markers; 1995 Oct 01; 10(1):42-6. PubMed ID: 7629426
    [Abstract] [Full Text] [Related]

  • 36. Sequential estimation of alkaline phosphatase isoenzymes (API) in breast cancer patients.
    Horner GU, Caffier HO.
    Cancer Detect Prev; 1981 Oct 01; 4(1-4):205-9. PubMed ID: 7349778
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical utility of the combined use of plurime tumor markers in human breast cancer.
    Neri B, Bartalucci S, Cataliotti L, Distante V, Tommasi M, Ciapini A.
    Cancer Detect Prev; 1988 Oct 01; 13(2):115-21. PubMed ID: 3072081
    [Abstract] [Full Text] [Related]

  • 39. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
    Voorzanger-Rousselot N, Juillet F, Mareau E, Zimmermann J, Kalebic T, Garnero P.
    Br J Cancer; 2006 Aug 21; 95(4):506-14. PubMed ID: 16880790
    [Abstract] [Full Text] [Related]

  • 40. [Significance of laboratory chemical parameters for the detection of metastases in breast cancer].
    Pirich K, Graninger W, Schneeweiss B, Schuster R, Lenzhofer R, Gabl F.
    Wien Klin Wochenschr; 1983 Nov 25; 95(22):778-81. PubMed ID: 6142567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.